180 related articles for article (PubMed ID: 26416158)
1. Mitochondrial ADP/ATP exchange inhibition: a novel off-target mechanism underlying ibipinabant-induced myotoxicity.
Schirris TJ; Ritschel T; Herma Renkema G; Willems PH; Smeitink JA; Russel FG
Sci Rep; 2015 Sep; 5():14533. PubMed ID: 26416158
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB
Iyer MR; Cinar R; Wood CM; Zawatsky CN; Coffey NJ; Kim KA; Liu Z; Katz A; Abdalla J; Hassan SA; Lee YS
J Med Chem; 2022 Feb; 65(3):2374-2387. PubMed ID: 35084860
[TBL] [Abstract][Full Text] [Related]
3. Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists.
Sharma MK; Murumkar PR; Kanhed AM; Giridhar R; Yadav MR
Eur J Med Chem; 2014 May; 79():298-339. PubMed ID: 24747288
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, SAR and intramolecular hydrogen bonding pattern of 1,3,5-trisubstituted 4,5-dihydropyrazoles as potent cannabinoid CB(1) receptor antagonists.
Lange JH; van der Neut MA; den Hartog AP; Wals HC; Hoogendoorn J; van Stuivenberg HH; van Vliet BJ; Kruse CG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1752-7. PubMed ID: 20137935
[TBL] [Abstract][Full Text] [Related]
5. Characterization of drug-induced human mitochondrial ADP/ATP carrier inhibition.
Jaiquel Baron S; King MS; Kunji ERS; Schirris TJJ
Theranostics; 2021; 11(11):5077-5091. PubMed ID: 33859735
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo.
Varga B; Kassai F; Szabó G; Kovács P; Fischer J; Gyertyán I
Pharmacol Biochem Behav; 2017 Aug; 159():24-35. PubMed ID: 28666894
[TBL] [Abstract][Full Text] [Related]
7. Human Adenine Nucleotide Translocase (ANT) Modulators Identified by High-Throughput Screening of Transgenic Yeast.
Zhang Y; Tian D; Matsuyama H; Hamazaki T; Shiratsuchi T; Terada N; Hook DJ; Walters MA; Georg GI; Hawkinson JE
J Biomol Screen; 2016 Apr; 21(4):381-90. PubMed ID: 26746582
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 and Bax modulate adenine nucleotide translocase activity.
Belzacq AS; Vieira HL; Verrier F; Vandecasteele G; Cohen I; Prévost MC; Larquet E; Pariselli F; Petit PX; Kahn A; Rizzuto R; Brenner C; Kroemer G
Cancer Res; 2003 Jan; 63(2):541-6. PubMed ID: 12543814
[TBL] [Abstract][Full Text] [Related]
9. Modeling of ATP-ADP steady-state exchange rate mediated by the adenine nucleotide translocase in isolated mitochondria.
Metelkin E; Demin O; Kovács Z; Chinopoulos C
FEBS J; 2009 Dec; 276(23):6942-55. PubMed ID: 19860824
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis.
Temkin V; Huang Q; Liu H; Osada H; Pope RM
Mol Cell Biol; 2006 Mar; 26(6):2215-25. PubMed ID: 16507998
[TBL] [Abstract][Full Text] [Related]
11. JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities.
Chorvat RJ; Berbaum J; Seriacki K; McElroy JF
Bioorg Med Chem Lett; 2012 Oct; 22(19):6173-80. PubMed ID: 22959249
[TBL] [Abstract][Full Text] [Related]
12. A novel kinetic assay of mitochondrial ATP-ADP exchange rate mediated by the ANT.
Chinopoulos C; Vajda S; Csanády L; Mándi M; Mathe K; Adam-Vizi V
Biophys J; 2009 Mar; 96(6):2490-504. PubMed ID: 19289073
[TBL] [Abstract][Full Text] [Related]
13. A kinetic assay of mitochondrial ADP-ATP exchange rate in permeabilized cells.
Kawamata H; Starkov AA; Manfredi G; Chinopoulos C
Anal Biochem; 2010 Dec; 407(1):52-7. PubMed ID: 20691655
[TBL] [Abstract][Full Text] [Related]
14. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease.
Walther T; Tschöpe C; Sterner-Kock A; Westermann D; Heringer-Walther S; Riad A; Nikolic A; Wang Y; Ebermann L; Siems WE; Bader M; Shakibaei M; Schultheiss HP; Dörner A
Circulation; 2007 Jan; 115(3):333-44. PubMed ID: 17210842
[TBL] [Abstract][Full Text] [Related]
15. The ADP and ATP transport in mitochondria and its carrier.
Klingenberg M
Biochim Biophys Acta; 2008 Oct; 1778(10):1978-2021. PubMed ID: 18510943
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes.
Perwitz N; Wenzel J; Wagner I; Büning J; Drenckhan M; Zarse K; Ristow M; Lilienthal W; Lehnert H; Klein J
Diabetes Obes Metab; 2010 Feb; 12(2):158-66. PubMed ID: 19895638
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the systems of activation of fatty acids and ademine nucleotide translocase in the mitochondria].
Konstantinov IuM; Liakhovich VV; Panov AV
Biull Eksp Biol Med; 1976 Oct; 82(10):1200-2. PubMed ID: 1029502
[TBL] [Abstract][Full Text] [Related]
18. Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects. Implications for a mechanism linking obesity and type 2 diabetes.
Ciapaite J; Bakker SJ; Diamant M; van Eikenhorst G; Heine RJ; Westerhoff HV; Krab K
FEBS J; 2006 Dec; 273(23):5288-302. PubMed ID: 17059463
[TBL] [Abstract][Full Text] [Related]
19. Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier.
Receveur JM; Murray A; Linget JM; Nørregaard PK; Cooper M; Bjurling E; Nielsen PA; Högberg T
Bioorg Med Chem Lett; 2010 Jan; 20(2):453-7. PubMed ID: 20015647
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria.
Puranam KL; Wu G; Strittmatter WJ; Burke JR
Biochem Biophys Res Commun; 2006 Mar; 341(2):607-13. PubMed ID: 16427603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
